Cargando…
Is teicoplanin a complementary treatment option for COVID-19? The question remains
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V. and International Society of Chemotherapy.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245324/ https://www.ncbi.nlm.nih.gov/pubmed/32454071 http://dx.doi.org/10.1016/j.ijantimicag.2020.106029 |
| _version_ | 1783537735179436032 |
|---|---|
| author | Ceccarelli, Giancarlo Alessandri, Francesco d'Ettorre, Gabriella Borrazzo, Cristian Spagnolello, Ornella Oliva, Alessandra Ruberto, Franco Mastroianni, Claudio M. Pugliese, Francesco Venditti, Mario |
| author_facet | Ceccarelli, Giancarlo Alessandri, Francesco d'Ettorre, Gabriella Borrazzo, Cristian Spagnolello, Ornella Oliva, Alessandra Ruberto, Franco Mastroianni, Claudio M. Pugliese, Francesco Venditti, Mario |
| author_sort | Ceccarelli, Giancarlo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7245324 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier B.V. and International Society of Chemotherapy. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72453242020-05-26 Is teicoplanin a complementary treatment option for COVID-19? The question remains Ceccarelli, Giancarlo Alessandri, Francesco d'Ettorre, Gabriella Borrazzo, Cristian Spagnolello, Ornella Oliva, Alessandra Ruberto, Franco Mastroianni, Claudio M. Pugliese, Francesco Venditti, Mario Int J Antimicrob Agents Letter to the Editor Elsevier B.V. and International Society of Chemotherapy. 2020-08 2020-05-23 /pmc/articles/PMC7245324/ /pubmed/32454071 http://dx.doi.org/10.1016/j.ijantimicag.2020.106029 Text en © 2020 Elsevier B.V. and International Society of Chemotherapy. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Ceccarelli, Giancarlo Alessandri, Francesco d'Ettorre, Gabriella Borrazzo, Cristian Spagnolello, Ornella Oliva, Alessandra Ruberto, Franco Mastroianni, Claudio M. Pugliese, Francesco Venditti, Mario Is teicoplanin a complementary treatment option for COVID-19? The question remains |
| title | Is teicoplanin a complementary treatment option for COVID-19? The question remains |
| title_full | Is teicoplanin a complementary treatment option for COVID-19? The question remains |
| title_fullStr | Is teicoplanin a complementary treatment option for COVID-19? The question remains |
| title_full_unstemmed | Is teicoplanin a complementary treatment option for COVID-19? The question remains |
| title_short | Is teicoplanin a complementary treatment option for COVID-19? The question remains |
| title_sort | is teicoplanin a complementary treatment option for covid-19? the question remains |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245324/ https://www.ncbi.nlm.nih.gov/pubmed/32454071 http://dx.doi.org/10.1016/j.ijantimicag.2020.106029 |
| work_keys_str_mv | AT ceccarelligiancarlo isteicoplaninacomplementarytreatmentoptionforcovid19thequestionremains AT alessandrifrancesco isteicoplaninacomplementarytreatmentoptionforcovid19thequestionremains AT dettorregabriella isteicoplaninacomplementarytreatmentoptionforcovid19thequestionremains AT borrazzocristian isteicoplaninacomplementarytreatmentoptionforcovid19thequestionremains AT spagnolelloornella isteicoplaninacomplementarytreatmentoptionforcovid19thequestionremains AT olivaalessandra isteicoplaninacomplementarytreatmentoptionforcovid19thequestionremains AT rubertofranco isteicoplaninacomplementarytreatmentoptionforcovid19thequestionremains AT mastroianniclaudiom isteicoplaninacomplementarytreatmentoptionforcovid19thequestionremains AT pugliesefrancesco isteicoplaninacomplementarytreatmentoptionforcovid19thequestionremains AT vendittimario isteicoplaninacomplementarytreatmentoptionforcovid19thequestionremains AT isteicoplaninacomplementarytreatmentoptionforcovid19thequestionremains |